JBM Healthcare Limited (incorporated in the Cayman Islands; HKEX: 02161) filed its Monthly Return for the period ended 31 May 2026 on 1 June, confirming a stable capital structure throughout the month.

Authorised Share Capital • Authorised share capital remained unchanged at 5.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 50.00 million.

Issued and Treasury Shares • Issued shares stood flat at 822.00 million. • No treasury shares were outstanding or transacted. • The company reported zero share issuances, cancellations, repurchases, or transfers, resulting in no change to paid-up capital or cash inflows from equity activities during the month.

Public Float Compliance • Management confirmed adherence to the Main Board’s minimum public-float requirement of 25%, ensuring sufficient free-float liquidity in the market.

Share Option Scheme • The Share Option Scheme (approved 6 August 2024) showed: – Outstanding options: 0 – Options exercised in May: 0 – Shares still available for future issuance under the scheme: 83.38 million

Regulatory Confirmation The company stated that all statutory and listing-rule obligations have been duly satisfied, with no discrepancies in share class uniformity or settlement procedures.

With no equity movements recorded in May 2026, JBM Healthcare enters June maintaining an authorised capital of HKD 50.00 million and an issued base of 822.00 million ordinary shares.